Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PepGen Inc. | 16,000 | reported | 04 Jun 2025 | tx 5+50,999 |
| Immuneering Corp | 7,888 | reported | 01 Jan 2026 | tx 9+150,652 |
| ALNYLAM PHARMACEUTICALS, INC. | 5,132 | reported | 05 Aug 2021 | tx 130+413,986−427,138 |
| Imago BioSciences, Inc. | 0 | reported | 11 Jan 2023 | tx 4+35,713−35,713 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jan 2026 | GRANT_AWARD | Immuneering Corp | 7,888 | 0.00 USD | deriv |
| 13 Jun 2025 | GRANT_AWARD | Immuneering Corp | 33,350 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | PepGen Inc. | 16,000 | 0.00 USD | deriv |
| 01 Jan 2025 | GRANT_AWARD | Immuneering Corp | 23,485 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | PepGen Inc. | 13,000 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | Immuneering Corp | 33,350 | 0.00 USD | deriv |
| 01 Jan 2024 | GRANT_AWARD | Immuneering Corp | 6,879 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | PepGen Inc. | 12,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Immuneering Corp | 17,500 | 0.00 USD | deriv |
| 06 May 2022 | PURCHASE | PepGen Inc. | 4,166 | 12.00 USD | |
| 11 Jan 2023 | OTHER | Imago BioSciences, Inc. | 11,904 | — | deriv |
| 11 Jan 2023 | OTHER | Imago BioSciences, Inc. | 23,809 | — | deriv |
| 21 Jun 2022 | GRANT_AWARD | Immuneering Corp | 14,200 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Imago BioSciences, Inc. | 11,904 | 0.00 USD | deriv |
| 16 May 2022 | PURCHASE | Immuneering Corp | 7,000 | 5.00 USD | |
| 06 May 2022 | GRANT_AWARD | PepGen Inc. | 5,833 | 0.00 USD | deriv |
| 17 Nov 2021 | GRANT_AWARD | Imago BioSciences, Inc. | 23,809 | 0.00 USD | deriv |
| 05 Aug 2021 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 7,876 | 88.95 USD | |
| 05 Aug 2021 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 2,124 | 88.95 USD | |
| 05 Aug 2021 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 10,000 | 188.95 USD | |
| 05 Aug 2021 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 2,124 | 0.00 USD | deriv |
| 05 Aug 2021 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 7,876 | 0.00 USD | deriv |
| 03 Aug 2021 | PURCHASE | Immuneering Corp | 7,000 | 15.00 USD | first after silence |
| 12 Jul 2021 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 1,812 | 85.00 USD | |
| 12 Jul 2021 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 5,000 | 178.95 USD |
1 purchase reported after at least 12 months of silence — most recent on 03 Aug 2021.